SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Smit H.)
 

Search: WFRF:(Smit H.) > (2020-2024) > Dopaminergic and se...

Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients

Timmers, Elze R. (author)
University Medical Center Groningen
van Faassen, Martijn (author)
University Medical Center Groningen
Smit, Marenka (author)
University Medical Center Groningen
show more...
Kuiper, Anouk (author)
University Medical Center Groningen
Hof, Ingrid H. (author)
University Medical Center Groningen
Kema, Ido P. (author)
University Medical Center Groningen
Tijssen, Marina A.J. (author)
University Medical Center Groningen
Niezen-Koning, Klary E. (author)
University Medical Center Groningen
de Koning, Tom J. (author)
Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,University Medical Center Groningen
show less...
 (creator_code:org_t)
Elsevier BV, 2021
2021
English.
In: Parkinsonism and Related Disorders. - : Elsevier BV. - 1353-8020. ; 91, s. 48-54
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Introduction: In dystonia, dopaminergic alterations are considered to be responsible for the motor symptoms. Recent attention for the highly prevalent non-motor symptoms suggest also a role for serotonin in the pathophysiology. In this study we investigated the dopaminergic, serotonergic and noradrenergic metabolism in blood samples of dystonia patients and its relation with (non-)motor manifestations. Methods: Concentrations of metabolites of dopaminergic, serotonergic and noradrenergic pathways were measured in platelet-rich plasma in 41 myoclonus-dystonia (M-D), 25 dopa-responsive dystonia (DRD), 50 cervical dystonia (CD) patients and 55 healthy individuals. (Non-)motor symptoms were assessed using validated instruments, and correlated with concentrations of metabolites. Results: A significantly higher concentration of 3-methoxytyramine (0.03 vs. 0.02 nmol/L, p < 0.01), a metabolite of dopamine, and a reduced concentration of tryptophan (50 vs. 53 μmol/L, p = 0.03), the precursor of serotonin was found in dystonia patients compared to controls. The dopamine/levodopa ratio was higher in CD patients compared to other dystonia groups (p < 0.01). Surprisingly, relatively high concentrations of levodopa were found in the untreated DRD patients. Low concentrations of levodopa were associated with severity of dystonia (rs = −0.3, p < 0.01), depression (rs = −0.3, p < 0.01) and fatigue (rs = −0.2, p = 0.04). Conclusion: This study shows alterations in the dopaminergic and serotonergic metabolism of patients with dystonia, with dystonia subtype specific changes. Low concentrations of levodopa, but not of serotonergic metabolites, were associated with both motor and non-motor symptoms. Further insight into the dopaminergic and serotonergic systems in dystonia with a special attention to the kinetics of enzymes involved in these pathways, might lead to better treatment options.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Keyword

Cervical dystonia
Dopa-responsive dystonia
Monoamine neurotransmitters
Myoclonus-dystonia
Non-motor symptoms

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view